News Releases

ContraPest® Deployment in Los Angeles, CA

FLAGSTAFF, Ariz., Aug. 27, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that the City of Los Angeles, CA will begin implementing ContraPest® into their current IPM programs with their city contracted pest company, Cats USA, at various locations.

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations. (PRNewsfoto/SenesTech, Inc.) (PRNewsfoto/SenesTech, Inc.)

Cats USA Pest Control provides residential and commercial service throughout Southern California using adaptive and innovative approaches at managing pests. Their goal is to promptly, safely and efficiently solve pest problems to create a safer, cleaner and greener environment for clients, their families and pets.

"Our ambition is to provide our customers with effective alternatives to the ever-growing concerns regarding anticoagulant rodenticides," said Michael Hunt, Service Manager of Cats USA. "ContraPest is a perfect fit and we are pleased to be able to integrate this state-of-the-art technology into our IPM portfolio."     

ContraPest will initially be deployed at six animal shelters located throughout the Los Angeles area where companion animal safety remains a priority. An estimated 65 ContraPest stations will be installed across the animal shelters to provide a non-lethal approach at managing rodent populations at these facilities. SenesTech and Cats USA are working closely with the city, collaborating on additional deployments in populated downtown areas where rodent control remains a priority.

"Working with Michael and the city officials is a great opportunity for us. This will not only aid us in expanding ContraPest throughout California, this also aligns with SenesTech's vision of continuing to make animal safety and wildlife protection a priority," stated Brandy Pyzyna, Vice President of Scientific Operations and Technical Services.

About SenesTech 

SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.

ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.

We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at

Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. Forward looking statements include, but are not limited to, our expectation regarding sales commitments, our expectation regarding the conversion of sales commitments and programs to revenue, our belief that our product is more humane, less harmful to the environment and more effective than traditional methods, and our belief that ContraPest will establish a new paradigm in rodent control without environmental effects of rodenticides.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.


Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

SOURCE SenesTech, Inc.